slides · global inventory
Legend
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,863
Current window 10,411-10,440
Pages 463
Rows per page 30
Component
10,411-10,440 of 13,863
19
The slide demonstrates that Variant A* shows higher potency than the wild-type trastuzumab in both binding and ADCC assays.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
23
The slide highlights the challenge of binding affinity (Kd) for the beta variant (607 nM) compared to others, using molecular visualization of RBD mutations.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
39
The chart uses a grouped bar chart to illustrate the economic structure across five categories: Research Funding/Cost, Upfront Payment, Clinical Milestones, Commercial Milestones, and Royalties.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 1 hit
04
The slide highlights the pharmacodynamic (PD) effect of background corticosteroids in the placebo group, which was unexpected.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · InterestLoop · Aha Moment1 hit
29
The slide uses a Gantt-style timeline to show the duration of IP protection and exclusivity for various therapeutic assets.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
10
The chart displays capital allocation trends over time, with a specific callout for Q1 FY24.Factset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
35
The chart illustrates clinical trial efficacy data for NXC-201.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
57
The slide compares efficacy benchmarks of established competitors (AbbVie, J&J, Takeda) to set a baseline for the IMX-120 opportunity.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
14
The chart highlights a significant improvement in profitability in 2023 compared to 2022.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
53
This appears to be the first slide in a sequence illustrating a workflow or customer journey.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
66
Chart shows pro forma revenue including TVS acquisition; CAGR calculated using top end of 2023 guidance.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · Business Model1 hit
68
Includes IPO and TVS Acquisition markers; 2023 Guide includes a range indicator.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · Business Model1 hit
08
Includes recent acquisitions (Valentino, Lindberg, Maui Jim, Creed) highlighted with arrows.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Call to Adventure1 hit
10
The slide highlights the 2022 dividend growth and provides a breakdown of the 2022 dividend payment dates.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Call to Adventure1 hit
18
The slide uses icons to represent each committee and provides a legend for acronyms used in the member list.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
20
Uses a custom legend with geometric shapes to categorize risks by theme (Creativity, Expertise, Growth, Talent, Sustainability).Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
43
The slide highlights 100 people dedicated to sustainability, split between corporate (50) and Houses (50).Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation1 hit
14
Data compares 'All HS Patients' vs 'Moderate to Severe' subgroups across four metrics over 42 days.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
16
Data presented as mean +/- S.E. of mean; N=7 patients.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
39
The chart is a swimmer plot, a standard tool in oncology clinical trials to visualize duration of response.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · Action1 hit
17
The slide uses a horizontal timeline format to map product milestones against calendar years.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
31
The chart shows a clear divergence between the treatment and placebo groups over time, with error bars indicating variability.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
18
The chart uses a baseline to show negative growth for several major hotel chains.Sonder | Investor Presentation Deck | 27 slides · Sonder
Pitch deck Investor relations Beat · Financials1 hit
09
The chart uses a dual-representation: a line graph for total applications and a bar chart for issued patents.Sonos | Investor Presentation Deck | 21 slides · Sonos
Pitch deck Investor relations Beat · The BreakthroughLoop · Golden Circle1 hit
28
The chart uses a stacked bar format to visualize cumulative growth over time.Sonos | Results Presentation Deck | 40 slides · Sonos
Conference presentation Investor relations Beat · Long-term Growth and Outlook1 hit
03
Includes footnotes regarding revenue composition, session definitions, and non-GAAP reconciliation.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · AttentionLoop · Logic Chain1 hit
07
The slide uses a grouped bar chart format to compare UBS and Credit Suisse performance metrics over five quarters.UBS | Results Presentation Deck | 31 slides · UBS
Conference presentation Investor relations Beat · Need1 hit
09
The chart highlights a significant reduction in store count, specifically noting that adjustments were mostly completed in 2022.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The chart displays two distinct metrics: a running balance of cash/investments (top row of ovals) and quarterly operating cashflow (bars).Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Action1 hit
14
Uses a custom framework to visualize synergy impact vs. assessment phase for four business functions.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Need1 hit